Cynosure, which develops aesthetic treatment systems used to remove hair, treat lesions, rejuvenate skin and reduce the appearance of cellulite, filed for an initial public offering with the SEC on Thursday night. The company generated $48 million in revenue from sales of its systems in the twelve months ended June 2005. Citigroup is the lead underwriter on the deal. Pricing terms were not disclosed in the initial filing.
